Avicanna Inc. (AVCN) Earnings Call Transcripts

Avicanna Inc.'s Latest Earnings Call - April 7, 2026

In the first quarter of 2026, Avicanna Inc. reported consistent revenue of $25.5 million for the fiscal year 2025, with a significant improvement in gross profit margin to 53%, up from 48% in the previous year. The company achieved an adjusted EBITDA loss of $300,000, a 71% improvement from a loss of $1 million in 2024, signaling enhanced operational efficiency. Management highlighted plans for international expansion and product launches in 2026, which could drive future growth and investor interest.

Reported metrics

Guidance from management

Management expressed optimism for 2026, focusing on international expansion and the launch of new products. They aim to leverage their asset-light model to scale operations without significant capital expenditures.

What management said

[Operator Instructions] If we have no questions, you're always welcome to e-mail the team at Avicanna. We're always open to discussing anything and look forward to your feedback. We'll give it 1 more minute. [Operator Instructions] All right, Barbara.

I think we'll wrap up here. Everyone, thank you for attending. Thank you for your interest in the company. We're happy to keep you updated, especially as we make further progress in 2026. We will be conducting more and more calls, updates, webinars, et cetera, and excited to deliver the results of this year for 2. Thank you. Thanks, Karolina. Thanks, Nick.

What analysts pressed on

Analysts raised concerns regarding the stock's performance amid oversupply issues from major shareholders. There are worries about the company's ability to maintain momentum in revenue growth while navigating regulatory challenges in international markets.

Main topics on the call

• Revenue Consistency — Avicanna reported revenue of $25.5 million for 2025, consistent with the previous year. CEO Aras Azadian stated, "We were able to relatively consistent revenues from last year, a little bit above last year's results."
• Improved Gross Margins — The company achieved a gross profit margin of 53%, a 10% increase from 48% in 2024. CFO Nick Hilborn noted, "The improved gross margin is a result of increased service and licensing revenue as well as a higher sell-throu...
• Adjusted EBITDA Improvement — Avicanna's adjusted EBITDA loss improved to $300,000 in 2025 from a loss of $1 million in 2024, marking a 71% improvement. Hilborn stated, "As a result, we achieved adjusted EBITDA positivity in the fourth quarter of 202...
• International Expansion Plans — Management plans to expand into 24 international markets, with a focus on scaling operations in Colombia and entering new markets like Australia. Azadian remarked, "We believe this can be something that's going to be sca...

Read the full Avicanna Inc. transcript (April 7, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 9 Avicanna Inc. earnings call transcripts on record, spanning May 17, 2023 to May 7, 2026. Based on this history, Avicanna Inc. reports semi-annually. The most recent call on file is dated May 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

AVCN

Exchange

TSX

Country

CA

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

9

First call

May 17, 2023

Most recent

May 7, 2026

Reporting cadence

semi-annually